Top 10

Gli articoli più visti nel mese di Luglio 2019

		Problemi correnti - Giugno 2000
1	19 kB	Trattare la mononucleosi? M. Fontana Abstract Symptoms are usually mild in young children, but in older children and adolescents systemic and pharingeal complains can be more severe, sometimes with significant airway obstruction. Only supportive care is usually recommended. This paper reports the risults of a recent meta-analysis reviewing the use of acyclovir in IM. This review concludes that acyclovir is effective when administred whithin the first seventytwo hours from the onset of the disease and recommends acyclovir for immunocompromised patients. Pros and cons of steroids treatment is also discussed and the authors conclude that the risks outweigh the benefits.

		ABC - Febbraio 2004
2	213 kB	Leggere l’emocromo I. Bruno

		Per una pediatria basata sull'evidenza - Giugno 2000
3	38 kB	Varicella e aciclovir E. Neri, I. Bruno, C. Salvatore, F. Braida, E. Barbi Abstract Chicken pox is still a common disease, usually with a favourable course. Complications are rare (2-3/100.000) in immunocompetent patients. The Authors review the published experience regarding treatment with acyclovir and conclude that the advantage is marginall (25% reduction of the duration of symptoms), while there is no reduction in the rate of complications. Acyclovir should be used in immunocompromised patients including primary immune deficiencies, patients treated with steroids or long-term salycilates, patients affected by chronic lung diseases, eczema, diabetes and heart diseases.

		La pagina gialla - Giugno 2019 a cura di Alessandro Ventura
4	118 kB	Indimenticabili Diagnosi di autismo prima dei 18 mesi: si può (si deve?) Curare al meglio la TBC: “DOT o VOT? Questo è il dilemma” Troppo grassi per fare la dieta Pediatria alla grande: il caso della acondroplasia Cercare gli eosinofili prima di dare il cortisone nell’asma

		Aggiornamento monografico - Febbraio 1997
5	193 kB	I disturbi del sonno nel bambino F. Cordelli Abstract The author syntetizes current knowedge on sleep physiology, particulary regarding REM and non REM sleep. There are many physiological motor and autonomic phenomena related to sleep such as gestual activity, modifications of hearth rate, respiratory rate and temperature. They should not be seen as abnormalities. When evaluating the child with insomnia, paediatricians should take into account the different sleep requirements at different ages, as well as environmental factors such as rituals utilized to induce sleep, fears, and stress. In infants, insomnia may be caused by allergy. Airway obstruction due to hypertrophic tonsils or adenoids may cause severe sleep disturbances, and negatively affect the child during the day. Pharmacological treatment of sleep disorders should be limited to cases not-responders to behavioural approaches or to elimination diet. Ipersomnias (narcolepsia, catalepsia, ipnagogic allucinations) are very rare in children and differential diagnosis with epilepsia may be diffucult. Parasomnias (iactatio capitis, spasmus rutans, pavor nocturnus, sonnambulism, bruxism) are easy to recognize and need just reassurance.

		Problemi non correnti - Settembre 1997
6	114 kB	APEC: esantema periflessurale asimmetrico M. Cutrone Abstract The paper describes a new entity, the Asymmetric Periflexural Exanthem of Childhood (APEC), first described in 1962 and recently recognized as a separate clinical entity by many Authors. It is characterized by scarlatiniform or papular rash which develops usually from a periflexural (axillary or inguinal) area to the thoracic area but with a clear monolateral preference. Respiratory or gastrointestinal symptoms may accompany the eruption. Occasionally moderate pruritus and regional lymphoadenopathy are present. The course is self-limited. This entity is believed to be caused by a virus but no single agent has been identified as a causal agent sofar. The Authors observed 4 cases of APEC over a period of four months in 18 to 24-month old children. It is probable that APEC can be diagnosed more often if increased attention is payed by paediatricians.

		Aggiornamento monografico - Febbraio 2001
7	84 kB	Le microcitosi nel bambino: classificazione e approccio diagnostico A. Sciotto, V. Furia, S.E. Munda Abstract The Authors provide an overview of microcytic anemias. Causes of microcytic anemia include a wide variety of diseases, the most common being iron-deficiency, impaired haemoglobin synthesis, sideroblastic anemias and anemias due to chronic disease. Other less common causes are copper deficiency, lead poisoning and haemosiderosis. A classification of the main microcytic anemias is provided and a diagnostic approach to microcytosis, with and without anemia, based on RDW and MCV is suggested.

		Aggiornamento - Giugno 2019
8	1342 kB	Ma che fine fanno gli SGA? G. Tornese Ogni pediatra non dovrebbe dimenticare di riguardare i dati neonatali per non perdere un bambino nato SGA. I motivi sono diversi. Abstract Recombinant human growth hormone (rhGH) is an approved and effective treatment for short children born small for gestational age (SGA). Prevalence of children eligible for treatment as SGA is reported to be 1:1,800. The latest data from the Italian National Registry of Growth Hormone therapy (RNAOC) showed that the number of children treated with SGA indication is still small and these children are significantly less reported than those treated for growth hormone deficiency (GHD), although GHD prevalence is 1:4,000- 1:10,000. This means that many short children born SGA are still not properly identified, and therefore not treated with rhGH, or misdiagnosed as GHD. This article reviews indications and benefits of rhGH treatment, reports some cases of treated children and provides some practical tools for the identification of children eligible for rhGH treatment.

		Editoriali - Giugno 2019
9	39 kB	L’ecografia, il pediatra e il radiologo: miti e realtà P. Tomà Il progresso tecnologico, il fronte continuo delle richieste di indagini ecografiche con nuove indicazioni (vedi polmoniti) e le sagge riflessioni per un uso basato sulla ragionevolezza.

		Farmacoriflessioni - Giugno 2019
10	220 kB	Storia delle evidenze sull’uso pediatrico dei farmaci antiemetici F. Marchetti È una storia lunga e istruttiva che mette a confronto, nel momento della prescrizione di un principio attivo, le evidenze scientifiche rispetto alle indicazioni riportate nelle “etichette” del farmaco. Abstract On 2nd May 2019 the Italian Medicines Agency (AIFA) issued an “Informative Note agreed upon with the European Regulatory Authorities” on domperidone entitled Memorandum on recommendations for minimising heart risks and eliminating prescriptions in Paediatrics. The note was drafted in collaboration with the authorised pharmaceutical companies that produce this drug. The present article reports the full note (because of its informative nature) and comments its case that has been lasting for many years making physicians think about the use of anti-emetics in Paediatrics both from a methodological and practical perspective.

inizio

Ultimi commenti

Eventi

I Tascabili di M&B

Referee 2018

MeB Social Network

Abbonamenti e servizi

Username e password

Scrivi un articolo

Strumenti

Link utili

Top 10

Username [perso?]
Password [persa?]